UK Our Work show submenu for Our Work About Us show submenu for About Us News show submenu for News Careers show submenu for Careers Search UK News Archive The UK News Archive contains resources intended for journalists only. Advanced Search Show: All Media Releases Stories All Media Releases Stories All October Media Release / Oct 28, 2021 Connecting Psoriasis and Psoriatic Arthritis - raising awareness of psoriatic disease Read More Media Release / Oct 28, 2021 Novartis Pharmaceuticals UK awarded an Innovation Passport for investigational oral therapy iptacopan (LNP023) Read More Media Release / Oct 19, 2021 Novartis awarded Promising Innovative Medicine designation for targeted radioligand theragnostics in prostate cancer Read More Media Release / Oct 05, 2021 The first treatment for sickle cell disease in over 20 years, Novartis’ Adakveo®▼ (crizanlizumab) receives NICE recommendation for preventing recurrent vaso-occlusive crises Read More September Media Release / Sep 20, 2021 Novartis unveils new data at ESMO 2021, including compelling longest ever reported median overall survival data in advanced breast cancer, as it continues to push the boundaries of innovation Read More Media Release / Sep 06, 2021 NICE recommends Novartis Cosentyx® (secukinumab) for children and young people with moderate to severe psoriasis Read More Media Release / Sep 01, 2021 World-first agreement between Novartis and the NHS enables broad and rapid access to first-in-class cholesterol-lowering medicine Leqvio®▼ (inclisiran) across England Read More Media Release / Sep 01, 2021 World-first agreement between Novartis and the NHS enables broad and rapid access to first-in-class cholesterol-lowering medicine Leqvio® ▼(inclisiran) Read More August Media Release / Aug 19, 2021 Novartis’ Rydapt ®▼ (midostaurin) is the first and only treatment to receive NICE recommendation for routine funding for patients in England and Wales living with advanced systemic mastocytosis (AdvSM) Read More July Media Release / Jul 26, 2021 Numbers that Matter report from Novartis reveals true burden of immune thrombocytopenia (ITP) and the impact of fatigue on UK patients’ quality of life Read More Search Results Navigation Current page 1 of 4 Page 2 of 4 Page 3 of 4 Page 4 of 4 Related Links General Privacy Notice for Suppliers General Privacy Notice for Business Partners Code Red – Switch-up on Sickle ITP Patient Resources You are here HomeNews Novartis UK Our Work About Us Partnerships News Careers Locations Contact us For UK Healthcare Professionals Subscribe to Novartis Facebook Twitter LinkedIn Novartis Global Website Directory © 2021 Novartis AG This site is intended for an audience in the United Kingdom Privacy Policy Accessibility Modern Slavery Statement Cookie Settings Your privacy is important for us. We use cookies to enhance your experience when visiting our websites: performance cookies show us how you use this website, functional cookies remember your preferences and targeting cookies help us to share content relevant to you. Select “Accept all” for giving your consent to all cookies, select “Cookie settings” for managing the different cookies or select “Reject all” for using only strictly necessary cookies. You can change your cookie settings at any point of time by pressing the cookie settings link on the website. Cookie Settings Reject all Accept all